At its meeting on March 20-23, 2023, the IASB met to continue its discussions on the application questions within the scope of this project with respect to (a) purchase of an additional interest in an associate while retaining significant influence; and (b) a perceived conflict between IFRS 10, Consolidated Financial Statements, and IAS 28, Investments in Associates and Joint Ventures. Following a discussion, the IASB made tentative decisions with respect to both (a) and (b). The IASB will continue its discussions on the application questions within the scope of the project.

Review the IASB Update and podcast on the Board's Web site.

At its meeting on March 20-23, 2023, the IASB met to discuss issues related to this project. In particular, the IASB discussed: (a) some potential changes to IAS 36, Impairment of Assets, to reduce the cost and complexity of the impairment test of cash-generating units containing goodwill; and (b) the potential removal of some disclosure requirements from IFRS 3, Business Combinations. Following a discussion, the IASB made tentative decisions with respect to both (a) and (b). Once the IASB has made tentative decisions on all aspects of the project, it will consider whether the package of decisions meets the project objective and whether it will publish an exposure draft setting out its proposals.

Review the IASB Update and podcast on the Board's Web site.

At its meeting on March 20-23, 2023, the IASB met to redeliberate certain proposals in its Exposure Draft relating to:  (a) disclosure of operating expenses by nature; (b) management performance measures; (c) categories in the statement of profit or loss; and (d) entities with specified main business activities.  Following a discussion, the IASB made tentative decisions with respect to (a) to (d). The IASB will continue to redeliberate the project proposals. 

Review the IASB Update and podcast on the Board's Web site.